1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for China Pharmacovigilance Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in China Pharmacovigilance Market
4. China Pharmacovigilance Market by
Product
4.1. Preclinical
4.2. Phase I
4.3. Phase II
4.4. Phase III
4.5. Phase IV
5. China Pharmacovigilance Market by
Service Provider
5.1. In House
5.2. Contract Outsourcing
6. China Pharmacovigilance Market by Type
6.1. Type Dashboard
6.2. Spontaneous Reporting
6.3. Intensified ADR Reporting
6.4. Targeted Spontaneous Reporting
6.5. Other Types
7. China Pharmacovigilance Market by
End Use
7.1. Hospitals
7.2. Research Organizations
7.3. Industrial
8. Company Profiles
8.1. Company 1
8.2. Company 2
8.3. Company 3
8.4. Company 4
8.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for China Pharmacovigilance Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in China Pharmacovigilance Market
4. China Pharmacovigilance Market by
Product
4.1. Preclinical
4.2. Phase I
4.3. Phase II
4.4. Phase III
4.5. Phase IV
5. China Pharmacovigilance Market by
Service Provider
5.1. In House
5.2. Contract Outsourcing
6. China Pharmacovigilance Market by Type
6.1. Type Dashboard
6.2. Spontaneous Reporting
6.3. Intensified ADR Reporting
6.4. Targeted Spontaneous Reporting
6.5. Other Types
7. China Pharmacovigilance Market by
End Use
7.1. Hospitals
7.2. Research Organizations
7.3. Industrial
8. Company Profiles
8.1. Company 1
8.2. Company 2
8.3. Company 3
8.4. Company 4
8.5. Company 5